COMMUNIQUÉS West-GlobeNewswire

Hundreds Gather in Seattle in Support of Increasing Access to Mental Health Services in King County at SOUND Behavioral Health’s Annual SOUND of Hope Gala
11/12/2025
Second Annual Gala Fundraiser Exceeds SOUND’s Fundraising Goal to Help Open More Doors to Mental Health and Substance Abuse Services SEATTLE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In late November more than 400 community [...]
SEMCAP Health Leads $25 Million Series D Investment in SafeinHome
11/12/2025
WALNUT CREEK, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- SafeinHome , the nation’s leader in Remote Supports for individuals with intellectual and developmental disabilities (I/DD), today announced the successful first [...]
Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium
11/12/2025
RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard-to-heal wounds, announces that Chief Scientific Officer [...]
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
11/12/2025
Announces the launch news of the summit, helping to capture interest around longevity and biohacking trends. Paris, France, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Hypersanté , a leading organisation in longevity, biohacking [...]
Les billets sont maintenant en vente pour Importance Vitale : sommet national sur la santé des femmes
11/12/2025
Places limitées – réservez votre place dès aujourd’hui pour le sommet inaugural sur la santé des femmes. Tarif préférentiel jusqu'au 23 janvier TORONTO, 11 déc. 2025 (GLOBE NEWSWIRE) -- Les billets sont maintenant en [...]
Vitally Important: National Women’s Health Summit Tickets On Sale Now
11/12/2025
Limited quantity available – secure your spot for the inaugural summit on women’s health today. Early-bird pricing available until January 23 TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tickets are now on sale for [...]
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
11/12/2025
Antigen spreading was evaluated in a subset of Phase 2 patients to assess the ability of ELI-002 7P to broaden immune responses to personalized tumor neoantigens not present in the targeted immunotherapy 87% (13/15) of [...]
PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support
11/12/2025
Original Vitamin Patch Pioneer Introduces Comprehensive Dopamine Precursor Formula Backed by Clinical Research Las Vegas, NV, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Introductory Pricing: $19.95 with 30% December Discount [...]
ViroMissile Announces First-in-Human Phase I Trial of IDOV-Immune for Advanced Solid Tumors
11/12/2025
Study examines the safety and early efficacy of an oncolytic virus via a single intravenous dose SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- ViroMissile , Inc., a cancer immunotherapy company pioneering the IDOV™ ( [...]
Stryker declares an $0.88 per share quarterly dividend
11/12/2025
Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at [...]
Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment
11/12/2025
Company announces agreement with FDA on human approval pathway based on Animal Rule Varespladib has received FDA MUMS designation for treatment of snakebite in dogs Animal health leader Aaron Schacht joins Board of [...]
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
11/12/2025
6-month commercial pilot demonstrated increasing demand among prescribers Expansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaign Additional clinical [...]
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
11/12/2025
Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HIT It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing, distinguishing [...]
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
11/12/2025
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection [...]
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
11/12/2025
Ra’anana, Israel, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced new results [...]
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
11/12/2025
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery [...]
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
11/12/2025
Patients treated with 0.05% urcosimod demonstrated directionally favorable improvements in nerve fiber count and fiber length, trends not observed in the placebo group These findings suggest that urcosimod may have a [...]
NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company
11/12/2025
TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials [...]
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026
11/12/2025
The Accepted Abstract Provides Supportive Evidence for the TAMP™ Therapy Platform’s Novel, Localized Approach to Targeted Chemotherapeutic Delivery via Additional Pharmacokinetic and Pharmacodynamic Data MOUNTAIN VIEW, [...]

Pages